These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31165445)

  • 1. Incidence of adverse reactions caused by first-line anti-tuberculosis drugs and treatment outcome of pulmonary tuberculosis patients in Morocco.
    El Hamdouni M; Ahid S; Bourkadi JE; Benamor J; Hassar M; Cherrah Y
    Infection; 2020 Feb; 48(1):43-50. PubMed ID: 31165445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi-centric prospective study.
    El Hamdouni M; Bourkadi JE; Benamor J; Hassar M; Cherrah Y; Ahid S
    BMC Infect Dis; 2019 Apr; 19(1):316. PubMed ID: 30975090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and outcomes of adverse drug reactions to first-line anti-tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study.
    Choi H; Park HA; Hyun IG; Kim JH; Hwang YI; Jang SH; Sim YS; Shin TR; Ko Y; Ban GY; Hong JY; Lee CY; Lee MG; Choi JH
    Pharmacoepidemiol Drug Saf; 2022 Nov; 31(11):1153-1163. PubMed ID: 35909258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy.
    Gualano G; Mencarini P; Musso M; Mosti S; Santangelo L; Murachelli S; Cannas A; Di Caro A; Navarra A; Goletti D; Girardi E; Palmieri F
    PLoS One; 2019; 14(2):e0212948. PubMed ID: 30817779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the change in the antitubercular regimen from three to four drugs on cure and frequency of adverse reactions in tuberculosis patients from Brazil: A retrospective cohort study.
    Arriaga MB; Torres NMC; Araujo NCN; Caldas SCC; Andrade BB; Netto EM
    PLoS One; 2019; 14(12):e0227101. PubMed ID: 31877199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of adverse reactions induced by anti-tuberculosis drugs among hospitalized patients in Wuhan, China: A retrospective study.
    Shi C; Yang B; Yang J; Song W; Chen Y; Zhang S; Zhan H; Xiong Y; Rong P; Luo Y; Yang J
    Medicine (Baltimore); 2024 May; 103(20):e38273. PubMed ID: 38758847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koulla-Shiro S
    East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Risk Factors Associated with Adverse Drug Reactions among Previously Treated Tuberculosis Patients in China.
    Han XQ; Pang Y; Ma Y; Liu YH; Guo R; Shu W; Huang XR; Ge QP; DU J; Gao WW
    Biomed Environ Sci; 2017 Feb; 30(2):139-142. PubMed ID: 28292352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Adverse Drug Reactions to First-Line Anti-Tuberculosis Drugs Using the Korea Adverse Event Reporting System.
    Chung SJ; Byeon SJ; Choi JH
    J Korean Med Sci; 2022 Apr; 37(16):e128. PubMed ID: 35470602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis drug safety and pharmacovigilance in health system of Kosova: A cross-sectional analysis.
    Krasniqi S; Neziri B; Jakupi A; Shurdhaj I; Daci A; Jupolli-Krasniqi N; Pira M
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1037-1045. PubMed ID: 32770586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.
    Costa GN; Magno LA; Santana CV; Konstantinovas C; Saito ST; Machado M; Di Pietro G; Bastos-Rodrigues L; Miranda DM; De Marco LA; Romano-Silva MA; Rios-Santos F
    Mol Diagn Ther; 2012 Aug; 16(4):241-50. PubMed ID: 22788240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Have we missed reporting adverse drug reactions under Revised National TB Control Programme?' - A mixed method study in Bengaluru, India.
    Krishnappa L; Gadicherla S; Chidambaram P; Anuradha HV; Somanna SN; Naik PR; Das A; Narasimhaiah S; Nagaraja SB
    Indian J Tuberc; 2020 Jan; 67(1):20-28. PubMed ID: 32192612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors of major toxicity associated to first-line antituberculosis drugs for latent and active tuberculosis during a period of 10 years.
    Castro AT; Mendes M; Freitas S; Roxo PC
    Rev Port Pneumol (2006); 2015; 21(3):144-50. PubMed ID: 25926250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events in the treatment of MDR-TB patients within and outside the NTP in Pham Ngoc Thach hospital, Ho Chi Minh City, Vietnam.
    Hoa NB; Nhung NV; Khanh PH; Hai NV; Quyen BT
    BMC Res Notes; 2015 Dec; 8():809. PubMed ID: 26695761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to Anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia.
    Tesfahuneygn G; Medhin G; Legesse M
    BMC Res Notes; 2015 Sep; 8():503. PubMed ID: 26420164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events during treatment of drug-resistant tuberculosis: a comparison between patients with or without human immunodeficiency virus co-infection.
    Sagwa E; Ruswa N; Musasa JP; Mantel-Teeuwisse AK
    Drug Saf; 2013 Nov; 36(11):1087-96. PubMed ID: 23917883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions in tuberculosis and management.
    Prasad R; Singh A; Gupta N
    Indian J Tuberc; 2019 Oct; 66(4):520-532. PubMed ID: 31813444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serious Adverse Reactions From Anti-tuberculosis Drugs Among 599 Children Hospitalized for Tuberculosis.
    Li Y; Zhu Y; Zhong Q; Zhang X; Shu M; Wan C
    Pediatr Infect Dis J; 2017 Aug; 36(8):720-725. PubMed ID: 28060046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse reactions to antituberculosis drugs in in-hospital patients: Severity and risk factors.
    Vilariça AS; Diogo N; André M; Pina J
    Rev Port Pneumol; 2010; 16(3):431-51. PubMed ID: 20635058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.